Literature DB >> 16631462

Complementary and alternative medicine for advanced prostate cancer.

J Daniell Rackley1, Peter E Clark, M Craig Hall.   

Abstract

Complimentary and alternative medicines (CAM) have increased drastically in popularity in the past decade. These are largely in the form of nutritional supplements. Despite a wealth of information sources on the subject, the fundamental problem with CAM therapies is a dearth of evidence-based medicine. Advanced prostate cancer has significant long-term morbidity, and there is a growing interest in alternative and complimentary forms of therapy that will improve the outcomes of patients who have recurrent or advanced prostate cancer while obviating the need for more toxic forms of therapy. In this article we summarize the use of some of the more common CAM nutritional supplements and review the scientific data that are available to support their use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631462     DOI: 10.1016/j.ucl.2005.12.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  6 in total

Review 1.  Integrative medicine: complementary therapies and supplements.

Authors:  Barrie R Cassileth; Jyothirmai Gubili; K Simon Yeung
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

2.  Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.

Authors:  Ralph W deVere White; Alexander Tsodikov; Eschelle C Stapp; Stephanie E Soares; Hajime Fujii; Robert M Hackman
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  Evaluation of in vitro antioxidant and anticancer activity of Allophylus cobbe leaf extracts on DU-145 and PC-3 human prostate cancer cell lines.

Authors:  Shridhar C Ghagane; Shridevi I Puranik; Rajendra B Nerli; Murigendra B Hiremath
Journal:  Cytotechnology       Date:  2016-12-18       Impact factor: 2.058

Review 4.  Lycopene for the prevention of prostate cancer.

Authors:  Dragan Ilic; Kristian M Forbes; Craig Hassed
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 5.  The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence.

Authors:  Nina Pauline Holzapfel; Boris Michael Holzapfel; Simon Champ; Jesper Feldthusen; Judith Clements; Dietmar Werner Hutmacher
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

6.  Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ping Chen; Wenhao Zhang; Xiao Wang; Keke Zhao; Devendra Singh Negi; Li Zhuo; Mao Qi; Xinghuan Wang; Xinhua Zhang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.